BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 9165060)

  • 21. Internalized Receptor for Glucose-dependent Insulinotropic Peptide stimulates adenylyl cyclase on early endosomes.
    Ismail S; Gherardi MJ; Froese A; Zanoun M; Gigoux V; Clerc P; Gaits-Iacovoni F; Steyaert J; Nikolaev VO; Fourmy D
    Biochem Pharmacol; 2016 Nov; 120():33-45. PubMed ID: 27641811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
    Widmann C; Dolci W; Thorens B
    Mol Endocrinol; 1996 Jan; 10(1):62-75. PubMed ID: 8838146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors.
    Brubaker PL; Drucker DJ
    Recept Channels; 2002; 8(3-4):179-88. PubMed ID: 12529935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP).
    Hinke SA; Manhart S; Pamir N; Demuth H; W Gelling R; Pederson RA; McIntosh CH
    Biochim Biophys Acta; 2001 May; 1547(1):143-55. PubMed ID: 11343800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The amino terminal domain of the glucagon-like peptide-1 receptor is a critical determinant of subtype specificity.
    Graziano MP; Hey PJ; Strader CD
    Recept Channels; 1996; 4(1):9-17. PubMed ID: 8723643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.
    Wang JH; Inoue T; Higashiyama M; Guth PH; Engel E; Kaunitz JD; Akiba Y
    J Pharmacol Exp Ther; 2011 Nov; 339(2):464-73. PubMed ID: 21846840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors.
    Preitner F; Ibberson M; Franklin I; Binnert C; Pende M; Gjinovci A; Hansotia T; Drucker DJ; Wollheim C; Burcelin R; Thorens B
    J Clin Invest; 2004 Feb; 113(4):635-45. PubMed ID: 14966573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-level expression of the GLP-I receptor results in receptor desensitization.
    Fehmann HC; Pracht A; Göke B
    Pancreas; 1998 Oct; 17(3):309-14. PubMed ID: 9788547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological and functional characteristics of a novel low-molecular weight antagonist of glucose-dependent insulinotropic polypeptide receptor, SKL-14959, in vitro and in vivo.
    Nakamura T; Tanimoto H; Mizuno Y; Tsubamoto Y; Noda H
    Diabetes Obes Metab; 2012 Jun; 14(6):511-7. PubMed ID: 22192426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five out of six tryptophan residues in the N-terminal extracellular domain of the rat GLP-1 receptor are essential for its ability to bind GLP-1.
    Wilmen A; Van Eyll B; Göke B; Göke R
    Peptides; 1997; 18(2):301-5. PubMed ID: 9149304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway.
    Mazzocchi G; Rebuffat P; Meneghelli V; Malendowicz LK; Tortorella C; Gottardo G; Nussdorfer GG
    Peptides; 1999; 20(5):589-94. PubMed ID: 10465510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro.
    Gelling RW; Coy DH; Pederson RA; Wheeler MB; Hinke S; Kwan T; McIntosh CH
    Regul Pept; 1997 Apr; 69(3):151-4. PubMed ID: 9226399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling.
    Unson CG; Wu CR; Jiang Y; Yoo B; Cheung C; Sakmar TP; Merrifield RB
    Biochemistry; 2002 Oct; 41(39):11795-803. PubMed ID: 12269822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GIP(3-30)NH
    Gasbjerg LS; Christensen MB; Hartmann B; Lanng AR; Sparre-Ulrich AH; Gabe MBN; Dela F; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
    Diabetologia; 2018 Feb; 61(2):413-423. PubMed ID: 28948296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
    Tseng CC; Kieffer TJ; Jarboe LA; Usdin TB; Wolfe MM
    J Clin Invest; 1996 Dec; 98(11):2440-5. PubMed ID: 8958204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
    Al-Sabah S; Donnelly D
    Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships of glucose-dependent insulinotropic polypeptide (GIP).
    Hinke SA; Gelling R; Manhart S; Lynn F; Pederson RA; Kühn-Wache K; Rosche F; Demuth HU; Coy D; McIntosh CH
    Biol Chem; 2003 Mar; 384(3):403-7. PubMed ID: 12715891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The recombinant rat glucagon-like peptide-1 receptor, expressed in an alpha-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release.
    Dillon JS; Lu M; Bowen S; Homan LL
    Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):182-9. PubMed ID: 15789279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.